156 related articles for article (PubMed ID: 16915065)
1. Interobserver and intraobserver variability of standardized uptake value measurements in non-small-cell lung cancer.
Marom EM; Munden RF; Truong MT; Gladish GW; Podoloff DA; Mawlawi O; Broemeling LD; Bruzzi JF; Macapinlac HA
J Thorac Imaging; 2006 Aug; 21(3):205-12. PubMed ID: 16915065
[TBL] [Abstract][Full Text] [Related]
2. Interobserver variability among measurements of the maximum and mean standardized uptake values on (18)F-FDG PET/CT and measurements of tumor size on diagnostic CT in patients with pulmonary tumors.
Huang YE; Chen CF; Huang YJ; Konda SD; Appelbaum DE; Pu Y
Acta Radiol; 2010 Sep; 51(7):782-8. PubMed ID: 20707663
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of the quantitative metabolic volumetric measurement on 18F-FDG PET/CT in Stage IV nonsurgical small-cell lung cancer.
Liao S; Penney BC; Zhang H; Suzuki K; Pu Y
Acad Radiol; 2012 Jan; 19(1):69-77. PubMed ID: 22142679
[TBL] [Abstract][Full Text] [Related]
4. Correlation of PET standard uptake value and CT window-level thresholds for target delineation in CT-based radiation treatment planning.
Hong R; Halama J; Bova D; Sethi A; Emami B
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):720-6. PubMed ID: 17293230
[TBL] [Abstract][Full Text] [Related]
5. Standard uptake value predicts survival in non-small cell lung cancer.
Okereke IC; Gangadharan SP; Kent MS; Nicotera SP; Shen C; DeCamp MM
Ann Thorac Surg; 2009 Sep; 88(3):911-5; discussion 915-6. PubMed ID: 19699919
[TBL] [Abstract][Full Text] [Related]
6. Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection.
Downey RJ; Akhurst T; Gonen M; Vincent A; Bains MS; Larson S; Rusch V
J Clin Oncol; 2004 Aug; 22(16):3255-60. PubMed ID: 15310769
[TBL] [Abstract][Full Text] [Related]
7. Assessment of interobserver reproducibility in quantitative 18F-FDG PET and CT measurements of tumor response to therapy.
Jacene HA; Leboulleux S; Baba S; Chatzifotiadis D; Goudarzi B; Teytelbaum O; Horton KM; Kamel I; Macura KJ; Tsai HL; Kowalski J; Wahl RL
J Nucl Med; 2009 Nov; 50(11):1760-9. PubMed ID: 19837757
[TBL] [Abstract][Full Text] [Related]
8. The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer.
Ashamalla H; Rafla S; Parikh K; Mokhtar B; Goswami G; Kambam S; Abdel-Dayem H; Guirguis A; Ross P; Evola A
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1016-23. PubMed ID: 15979817
[TBL] [Abstract][Full Text] [Related]
9. Increased standardized uptake value in the primary lesion predicts nodal or distant metastases at presentation in lung cancer.
Sachs S; Bilfinger TV; Komaroff E; Franceschi D
Clin Lung Cancer; 2005 Mar; 6(5):310-3. PubMed ID: 15845183
[TBL] [Abstract][Full Text] [Related]
10. Interobserver and Intraobserver Variability among Measurements of FDG PET/CT Parameters in Pulmonary Tumors.
Büyükdereli G; Güler M; Şeydaoğlu G
Balkan Med J; 2016 May; 33(3):308-15. PubMed ID: 27308075
[TBL] [Abstract][Full Text] [Related]
11. Test-Retest Variability in Lesion SUV and Lesion SUR in
Hofheinz F; Apostolova I; Oehme L; Kotzerke J; van den Hoff J
J Nucl Med; 2017 Nov; 58(11):1770-1775. PubMed ID: 28473598
[TBL] [Abstract][Full Text] [Related]
12. High fluorodeoxyglucose uptake on positron emission tomography in patients with advanced non-small cell lung cancer on platinum-based combination chemotherapy.
Lee KH; Lee SH; Kim DW; Kang WJ; Chung JK; Im SA; Kim TY; Kim YW; Bang YJ; Heo DS
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4232-6. PubMed ID: 16857796
[TBL] [Abstract][Full Text] [Related]
13. 18F-FDG PET for mediastinal staging of lung cancer: which SUV threshold makes sense?
Hellwig D; Graeter TP; Ukena D; Groeschel A; Sybrecht GW; Schaefers HJ; Kirsch CM
J Nucl Med; 2007 Nov; 48(11):1761-6. PubMed ID: 17942814
[TBL] [Abstract][Full Text] [Related]
14. 18F-FDG uptake and EGFR mutations in patients with non-small cell lung cancer: a single-institution retrospective analysis.
Na II; Byun BH; Kim KM; Cheon GJ; Choe du H; Koh JS; Lee DY; Ryoo BY; Baek H; Lim SM; Yang SH; Kim CH; Lee JC
Lung Cancer; 2010 Jan; 67(1):76-80. PubMed ID: 19371962
[TBL] [Abstract][Full Text] [Related]
15. Integrated (18)F-FDG PET/CT and perfusion CT of primary colorectal cancer: effect of inter- and intraobserver agreement on metabolic-vascular parameters.
Goh V; Shastry M; Engledow A; Kozarski R; Peck J; Endozo R; Rodriguez-Justo M; Taylor SA; Halligan S; Groves AM
AJR Am J Roentgenol; 2012 Nov; 199(5):1003-9. PubMed ID: 23096172
[TBL] [Abstract][Full Text] [Related]
16. FDG PET/CT interobserver agreement in head and neck cancer: FDG and CT measurements of the primary tumor site.
Jackson T; Chung MK; Mercier G; Ozonoff A; Subramaniam RM
Nucl Med Commun; 2012 Mar; 33(3):305-12. PubMed ID: 22227560
[TBL] [Abstract][Full Text] [Related]
17. Reproducibility of "intelligent" contouring of gross tumor volume in non-small-cell lung cancer on PET/CT images using a standardized visual method.
Bayne M; Hicks RJ; Everitt S; Fimmell N; Ball D; Reynolds J; Lau E; Pitman A; Ware R; MacManus M
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1151-7. PubMed ID: 20610039
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Standardized Uptake Values in Normal Structures Between PET/CT and PET/MRI in a Tertiary Pediatric Hospital: A Prospective Study.
Lyons K; Seghers V; Sorensen JI; Zhang W; Paldino MJ; Krishnamurthy R; Rohren EM
AJR Am J Roentgenol; 2015 Nov; 205(5):1094-101. PubMed ID: 26496558
[TBL] [Abstract][Full Text] [Related]
19. 18F-fluoro-2-deoxy-glucose uptake predicts clinical outcome in patients with gefitinib-treated non-small cell lung cancer.
Na II; Byun BH; Kang HJ; Cheon GJ; Koh JS; Kim CH; Choe DH; Ryoo BY; Lee JC; Lim SM; Yang SH
Clin Cancer Res; 2008 Apr; 14(7):2036-41. PubMed ID: 18381942
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of different metabolic measurements with fluorine-18 fluorodeoxyglucose positron emission tomography in resectable non-small cell lung cancer: a two-center study.
de Jong WK; van der Heijden HF; Pruim J; Dalesio O; Oyen WJ; Groen HJ
J Thorac Oncol; 2007 Nov; 2(11):1007-12. PubMed ID: 17975491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
